IKKΒ leads to an inflammatory skin disease resembling interface dermatitis

Journal of Investigative Dermatology

Volumn 130, Issue 6, 2010, Pages 1598-1610

  Page, Angustias ^a   Navarro, Manuel ^a   Garín, Marina ^a   Pérez, Paloma ^b   Casanova, M Llanos ^a   Moreno, Rodolfo ^a   Jorcano, José L ^a   Cascallana, José L ^c,d   Bravo, Ana ^c   Ramírez, Angel ^a  

^a CIEMAT   (Spain)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d Galician Institute of Legal Medicine   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; I KAPPA B KINASE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IKBKB PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BASAL CELL; CELL DAMAGE; CELL DEGENERATION; CELL INFILTRATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS; ECTODERMAL DYSPLASIA; GENE OVEREXPRESSION; HAIR FOLLICLE; HISTOPATHOLOGY; IMMUNE RESPONSE; INTERFACE DERMATITIS; KERATINOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN INFLAMMATION; T LYMPHOCYTE; TRANSCRIPTOMICS; UPREGULATION; ANIMAL; DISEASE MODEL; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; DERMATITIS; DISEASE MODELS, ANIMAL; I-KAPPA B KINASE; IMMUNE SYSTEM; MICE; MICE, TRANSGENIC; NF-KAPPA B; PHENOTYPE; SIGNAL TRANSDUCTION; SKIN; T-LYMPHOCYTES;

EID: 77952429289     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.28     Document Type: Article

References (49)

1. Barton D, HogenEsch H, Weih F (2000) Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol 30:2323-2332
2. Baumann B, Wagner M, Aleksic T et al. (2007) Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest 117:1502-1513
3. Brummelkamp TR, Nijman SM, Dirac AM et al. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424:797-801
4. Cai D, Yuan M, Frantz DF et al. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183-190
5. Delhase M, Hayakawa M, Chen Y et al. (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphor-ylation. Science 284:309-313
6. Dennis Jr G, Sherman BT, Hosack DA et al. (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3
7. Descargues P, Sil AK, Karin M (2008) IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer. EMBO J 27:2639-2647
8. Gentleman R, Carey V, Bates D et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80
9. Greten FR, Eckmann L, Greten TF et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296
10. Gugasyan R, Voss A, Varigos G et al. (2004) The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Mol Cell Biol 24:5733-5745
11. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344-362
12. Hogan B, Beddington RCF, Lacy E (1994) Manipulating the mouse embryo. A laboratory manual. 2 edn. Cold Spring Harbor Laboratory Press: New York, 497 pp
13. th edn, Lippincott Williams & Wilkins: Philadelphia, 323-343
14. Hu MC, Lee DF, Xia W et al. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117:225-237
15. Irelan JT, Murphy TJ, DeJesus PD et al. (2007) A role for IkappaB kinase 2 in bipolar spindle assembly. Proc Natl Acad Sci USA 104:16940-16945
16. Kanters E, Pasparakis M, Gijbels MJ et al. (2003) Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112:1176-1185
17. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431-436
18. Klement JF, Rice NR, Car BD et al. (1996) IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol 16:2341-2349
19. Lee DF, Kuo HP, Chen CT et al. (2007) IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130:440-455
20. Li Q, Van Antwerp D, Mercurio F et al. (1999a) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321-325
21. Li ZW, Chu W, Hu Y et al. (1999b) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189:1839-1845
22. Maeda S, Kamata H, Luo JL et al. (2005) IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990
23. Makris C, Godfrey VL, Krahn-Senftleben G et al. (2000) Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermato-pathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 5:969-979
24. Meller S, Gilliet M, Homey B (2009) Chemokines in the pathogenesis of lichenoid tissue reactions. J Invest Dermatol 129:315-319
25. Mercurio F, Zhu H, Murray BW et al. (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278:860-866
26. Moreno-Maldonado R, Ramirez A, Navarro M et al. (2008) IKKalpha enhances human keratinocyte differentiation and determines the histological variant of epidermal squamous cell carcinomas. Cell Cycle (Georgetown, TX) 7:2021-2029
27. Nenci A, Huth M, Funteh A et al. (2006) Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum Mol Genet 15:531-542
28. Pasparakis M, Courtois G, Hafner M et al. (2002) TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417:861-866
29. Perez P, Page A, Bravo A et al. (2001) Altered skin development and impaired proliferative and inflammatory responses in transgenic mice over-expressing the glucocorticoid receptor. FASEB J 15:2030-2032
30. Perez P, Page A, Jorcano JL (2000) Role of phosphorylated p50-NF-kappaB in the ultraviolet response of mouse skin. Mol Carcinog 27:272-279
31. Pichler WJ, Yawalkar N, Britschgi M et al. (2002) Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 3:229-238
32. Prochazka M, Gaskins HR, Shultz LD et al. (1992) The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89:3290-3294
33. Ramirez A, Bravo A, Jorcano JL et al. (1994) Sequences 5 of the bovine keratin 5 gene direct tissue-and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58:53-64
34. Ramirez A, Page A, Gandarillas A et al. (2004) A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 39:52-57
35. Rebholz B, Haase I, Eckelt B et al. (2007) Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity 27:296-307
36. Robles AI, Larcher F, Whalin RB et al. (1996) Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci USA 93:7634-7638
37. Ruocco MG, Maeda S, Park JM et al. (2005) I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med 201:1677-1687
38. Sakurai H, Chiba H, Miyoshi H et al. (1999) IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356
39. Schmidt-Supprian M, Bloch W, Courtois G et al. (2000) NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell 5: 981-992
40. Seitz CS, Lin Q, Deng H et al. (1998) Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci USA 95:2307-2312
41. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3. E-pub ahead of print 12 February 2004.
42. Sontheimer RD (2009) Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. J Invest Dermatol 129:1088-1099
43. th edn, Lippincott Williams & Wilkins: Philadelphia, 705-713
44. Stratis A, Pasparakis M, Markur D et al. (2006) Localized inflammatory skin disease following inducible ablation of I kappa B kinase 2 in murine epidermis. J Invest Dermatol 126:614-620
45. Tanaka M, Fuentes ME, Yamaguchi K et al. (1999) Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10:421-429
46. van Hogerlinden M, Rozell BL, Ahrlund-Richter L et al. (1999) Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res 59:3299-3303
47. Vashisht Gopal YN, Arora TS, Van Dyke MW (2006) Tumour necrosis factor-alpha depletes histone deacetylase 1 protein through IKK2. EMBO Rep 7:291-296
48. Xia Y, Padre RC, De Mendoza TH et al. (2009) Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc Natl Acad Sci USA 106:2629-2634
49. Zaba LC, Krueger JG, Lowes MA (2009) Resident and " inflammatory" dendritic cells in human skin. J Invest Dermatol 129:302-308